6097-31-0 Usage
Uses
Used in Pharmaceutical Industry:
2-(3,4-dichlorophenyl)-3-oxobutanenitrile is utilized as a precursor in the synthesis of various pharmaceuticals, contributing to the development of new drugs and medications. Its chemical properties make it a valuable component in the creation of active pharmaceutical ingredients.
Used in Agrochemical Industry:
In the agrochemical sector, 2-(3,4-dichlorophenyl)-3-oxobutanenitrile is employed as a precursor for the synthesis of agrochemicals, which are essential for the development of pesticides and other agricultural products that protect crops and enhance agricultural productivity.
Used in Dye and Pigment Production:
2-(3,4-dichlorophenyl)-3-oxobutanenitrile is used as a key intermediate in the production of certain dyes and pigments, playing a critical role in the coloration processes of various materials and products in industries such as textiles, plastics, and printing inks.
Check Digit Verification of cas no
The CAS Registry Mumber 6097-31-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,0,9 and 7 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 6097-31:
(6*6)+(5*0)+(4*9)+(3*7)+(2*3)+(1*1)=100
100 % 10 = 0
So 6097-31-0 is a valid CAS Registry Number.
InChI:InChI=1/C10H7Cl2NO/c1-6(14)8(5-13)7-2-3-9(11)10(12)4-7/h2-4,8H,1H3
6097-31-0Relevant academic research and scientific papers
N -Acetyl-3-aminopyrazoles block the non-canonical NF-kB cascade by selectively inhibiting NIK
Pippione, Agnese C.,Sainas, Stefano,Federico, Antonella,Lupino, Elisa,Piccinini, Marco,Kubbutat, Michael,Contreras, Jean-Marie,Morice, Christophe,Barge, Alessandro,Ducime, Alex,Boschi, Donatella,Al-Karadaghi, Salam,Lolli, Marco L.
supporting information, p. 963 - 968 (2018/06/27)
NF-κB-inducing kinase (NIK), an oncogenic drug target that is associated with various cancers, is a central signalling component of the non-canonical pathway. A blind screening process, which established that amino pyrazole related scaffolds have an effect on IKKbeta, led to a hit-to-lead optimization process that identified the aminopyrazole 3a as a low μM selective NIK inhibitor. Compound 3a effectively inhibited the NIK-dependent activation of the NF-κB pathway in tumour cells, confirming its selective inhibitory profile.
